×
About 4,509 results

ALLMedicine™ Heparin-induced Thrombocytopenia Center

Research & Reviews  2,121 results

Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment.
https://doi.org/10.1080/17474086.2021.1905512
Expert Review of Hematology; Hvas AM, Favaloro EJ et. al.

Mar 19th, 2021 - Introduction: Immune-mediated heparin-induced thrombocytopenia (HIT) is an infrequent complication following heparin exposure but with potentially fatal outcome due to thrombotic complications. Prompt suspension of heparin is necessary if HIT is s...

Argatroban Anticoagulation for Adult Extracorporeal Membrane Oxygenation: A Systematic ...
https://doi.org/10.1177/0885066621993739
Journal of Intensive Care Medicine; Geli J, Capoccia M et. al.

Mar 3rd, 2021 - Heparin is the widely used anti-coagulation strategy for patients on extracorporeal membrane oxygenation (ECMO). Nevertheless, heparin-induced thrombocytopenia (HIT) and acquired anti-thrombin (AT) deficiency preclude the use of heparin requiring ...

Platelet-activating immune complexes identified in critically ill COVID-19 patients sus...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014456
Journal of Thrombosis and Haemostasis : JTH; Nazy I, Jevtic SD et. al.

Feb 27th, 2021 - Thrombocytopenia and thrombosis are prominent in coronavirus disease 2019 (COVID-19), particularly among critically ill patients; however, the mechanism is unclear. Such critically ill COVID-19 patients may be suspected of heparin-induced thromboc...

A population-based analysis on the use of therapeutic plasma exchange and intravenous i...
https://doi.org/10.1016/j.thromres.2021.02.017
Thrombosis Research; Soares Ferreira Júnior A, Boyle SH et. al.

Feb 23rd, 2021 - In heparin-induced thrombocytopenia (HIT), selected patients are treated with therapies directed at the immune response, intravenous immunoglobulin (IVIG) and therapeutic plasma exchange (TPE). To determine IVIG and TPE characteristics and outcome...

see more →

Guidelines  7 results

American Society of Hematology 2018 guidelines for management of venous thromboembolism...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258919
Blood Advances; Cuker A, Arepally GM et. al.

Nov 29th, 2018 - Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated by platelet-activating antibodies that target complexes of platelet factor 4 and heparin. Patients are at markedly increased risk of thromboembolism. These evidence-based ...

American Society of Hematology 2018 guidelines for management of venous thromboembolism: hep...
http://www.bloodadvances.org/content/2/22/3360
Cuker, A.

Nov 26th, 2018 - Background: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated by platelet-activating antibodies that target complexes of platelet factor 4 and heparin. Patients are at markedly increased risk of thromboembolism.

Heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopeni...
https://doi.org/10.1111/jth.13516
Journal of Thrombosis and Haemostasis : JTH; Morel-Kopp MC, Mullier F et. al.

Nov 19th, 2016 - Heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopenia testing: communication from the SSC of the ISTH.|2016|Morel-Kopp MC,Mullier F,Gkalea V,Bakchoul T,Minet V,|adverse effects,adverse effects,drug effects,instru...

Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second ...
https://doi.org/10.1111/bjh.12059
British Journal of Haematology; Watson H, Davidson S et. al.

Oct 9th, 2012 - Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition.|2012|Watson H,Davidson S,Keeling D, ,|adverse effects,adverse effects,chemically induced,diagnosis,therapy,

Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy an...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278058
Chest Linkins LA, Dans AL et. al.

Feb 14th, 2012 - Heparin-induced thrombocytopenia (HIT) is an antibody-mediated adverse drug reaction that can lead to devastating thromboembolic complications, including pulmonary embolism, ischemic limb necrosis necessitating limb amputation, acute myocardial in...

see more →

Drugs  77 results see all →

Clinicaltrials.gov  2,233 results

Immune Response May Explain Rare Clots After AstraZeneca Vaccine
https://www.medscape.com/viewarticle/948389

Mar 30th, 2021 - (Reuters) - Researchers may have found an explanation for the rare but serious blood clots reported among some people who received AstraZeneca's COVID-19 vaccine. They believe the phenomenon is similar to heparin-induced thrombocytopenia (HIT), in...

Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment.
https://doi.org/10.1080/17474086.2021.1905512
Expert Review of Hematology; Hvas AM, Favaloro EJ et. al.

Mar 19th, 2021 - Introduction: Immune-mediated heparin-induced thrombocytopenia (HIT) is an infrequent complication following heparin exposure but with potentially fatal outcome due to thrombotic complications. Prompt suspension of heparin is necessary if HIT is s...

Argatroban Anticoagulation for Adult Extracorporeal Membrane Oxygenation: A Systematic ...
https://doi.org/10.1177/0885066621993739
Journal of Intensive Care Medicine; Geli J, Capoccia M et. al.

Mar 3rd, 2021 - Heparin is the widely used anti-coagulation strategy for patients on extracorporeal membrane oxygenation (ECMO). Nevertheless, heparin-induced thrombocytopenia (HIT) and acquired anti-thrombin (AT) deficiency preclude the use of heparin requiring ...

Platelet-activating immune complexes identified in critically ill COVID-19 patients sus...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014456
Journal of Thrombosis and Haemostasis : JTH; Nazy I, Jevtic SD et. al.

Feb 27th, 2021 - Thrombocytopenia and thrombosis are prominent in coronavirus disease 2019 (COVID-19), particularly among critically ill patients; however, the mechanism is unclear. Such critically ill COVID-19 patients may be suspected of heparin-induced thromboc...

A population-based analysis on the use of therapeutic plasma exchange and intravenous i...
https://doi.org/10.1016/j.thromres.2021.02.017
Thrombosis Research; Soares Ferreira Júnior A, Boyle SH et. al.

Feb 23rd, 2021 - In heparin-induced thrombocytopenia (HIT), selected patients are treated with therapies directed at the immune response, intravenous immunoglobulin (IVIG) and therapeutic plasma exchange (TPE). To determine IVIG and TPE characteristics and outcome...

see more →

News  71 results

Immune Response May Explain Rare Clots After AstraZeneca Vaccine
https://www.medscape.com/viewarticle/948389

Mar 30th, 2021 - (Reuters) - Researchers may have found an explanation for the rare but serious blood clots reported among some people who received AstraZeneca's COVID-19 vaccine. They believe the phenomenon is similar to heparin-induced thrombocytopenia (HIT), in...

Choosing Wisely Champions Cut Blood RBC Transfusions, HIT testing
https://www.staging.medscape.com/viewarticle/906609

Dec 13th, 2018 - SAN DIEGO — Three clinicians were hailed as Choosing Wisely Champions here at the American Society of Hematology (ASH) 2018 annual meeting for their efforts to reduce overuse of treatments and tests. One clinician describes how his team managed to...

Choosing Wisely Champions Cut Blood RBC Transfusions, HIT testing
https://www.medscape.com/viewarticle/906609

Dec 13th, 2018 - SAN DIEGO — Three clinicians were hailed as Choosing Wisely Champions here at the American Society of Hematology (ASH) 2018 annual meeting for their efforts to reduce overuse of treatments and tests. One clinician describes how his team managed to...

Test for HIT receives CE mark
https://www.mdedge.com/hematology-oncology/article/185038/anemia/test-hit-receives-ce-mark
HT Staff

Apr 4th, 2018 - Platelet-rich plasma HIT Confirm, a test used to diagnose heparin-induced thrombocytopenia (HIT), has received the CE mark. This means the test meets regulatory requirements and health, safety, and environmental protection standards for products s.

see more →